Ketamine after the hype: What are we actually treating?
Year: 2026
Type: article
Abstract: ObjectiveKetamine has transformed depression research by demonstrating rapid antidepressant effects through mechanisms beyond monoaminergic neurotransmission. This perspective argues that the ketamine story also provides an opportunity to re-examine broader conceptual and methodological challenges in depression research, including the definition of treatment-resistant depression, patient selection, recruitment strategies, outcome measures and the interpretation of clinical trials.ConclusionsRather than questioning whether ketamine works, this perspective asks whether depression research generates evidence that meaningfully informs clinical decisions. Differences in patient populations, recruitment strategies, expectations and outcome measures may substantially shape treatment estimates. More precise clinical characterisation and greater emphasis on patient-important outcomes may help bridge the gap between efficacy demonstrated in trials and the choice of treatment for individual patients.
Source: Australasian Psychiatry
Author: Pouya Movahed Rad
Institution: Lund University
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,150
OpenAlex ID: W7235711798
